Hookipa Pharma Inc. Conducted Special Stockholder Meeting to Vote on Key Proposals
I'm PortAI, I can summarize articles.
Hookipa Pharma Inc. held a special stockholder meeting on July 29, 2025, where stockholders approved the sale of certain assets to Gilead Sciences, Inc. and the company's liquidation and dissolution as per the Plan of Dissolution. The proposal to adjourn the meeting for additional proxy solicitation was also approved.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments